AI-powered and patient-inspired. We accelerate the discovery and development of rare disease treatments.
51 - 200
π° $56M Series B on 2019-10
August 14
π Hybrid β Cambridge
β° Full Time
π Senior
π° Business Development (BDR)
π Skilled Worker Visa Sponsor